RANEEN JANINI: Open Payments
NPI 1215663885 · POMONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 7 payments from 5 companies in 2025. Trend: 2023 $50 · 2024 $85 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $51 |
| Organon LLC | 2 | $42 |
| Boston Scientific Corporation | 1 | $23 |
| Exeltis, USA Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
Products named: Veozah, NEXPLANON, Bulkamid, SLYND, MYFEMBREE.
Industry payments across CA — which companies pay providers there.
